BS

Balwant Singh Bedi

Active Director Additional Director DIN 07364499
DIN 07364499 First appointment Dec 2015 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Balwant Singh Bedi

Data last updated:

Balwant Singh Bedi is an Additional Director at Novezza Pharma Private Limited (since 2015). The company operates in Healthcare.

DIN 07364499
Primary Designation Additional Director
Industry Healthcare
First Appointment 10 Dec 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Novezza Pharma Private Limited U24290PB2015PTC039780
Additional Director10 Dec 20152015Active

Board colleagues of Balwant Singh Bedi

NameDINCompanyDesignation
Rupinder Kaur09546762Novezza Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Novezza Pharma Private Limited
Premium access

Shareholding and investment profile for Balwant Singh Bedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balwant Singh Bedi

Balwant Singh Bedi currently holds 1 directorship: Novezza Pharma Private Limited (Additional Director, since 10 Dec 2015).

Balwant Singh Bedi was first appointed on 10 Dec 2015 as Additional Director at Novezza Pharma Private Limited.

The current boards of Balwant Singh Bedi's companies include Rupinder Kaur (Novezza Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available